Uluç Yiş
Uluç Yiş has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Semra Hız Kurul
Department of Pediatric Neurology, Faculty of Medicine, Dokuz Eylül University, Izmir, Turkey
7 shared publications - Erhan Bayram
Dokuz Eylül University Medical Faculty
6 shared publications Derya Okur
4 shared publicationsMuge Ayanoglu
4 shared publicationsPinar Edem
4 shared publications- Yasemin Topcu
Division of Pediatric Neurology, Dokuz Eylul University Hospital, Izmir, Turkey
4 shared publications
Latest Publications
- 17 April 2023
- Published by Elsevier in Journal of Pediatric Nursing
- Vol. 72, 185-190
Evaluation of vincristine-induced peripheral neuropathy in children with cancer: Turkish validity and reliability study
- 17 April 2023
- Published by Elsevier in Journal of Pediatric Nursing
- Vol. 72, 185-190
Evaluation of vincristine-induced peripheral neuropathy in children with cancer: Turkish validity and reliability study
- 3 January 2023
- Published by Elsevier in Journal of Pediatric Nursing
- Vol. 69, 31-37
Examination of the psychometric properties of pediatric-modified total neuropathy score in Turkish children with cancer
- 3 January 2023
- Published by Elsevier in Journal of Pediatric Nursing
- Vol. 69, 31-37
Examination of the psychometric properties of pediatric-modified total neuropathy score in Turkish children with cancer
- 16 November 2022
- Published by Elsevier in Gait & Posture
- Vol. 99, 139-145
Factors associated with balance ability in Duchenne and Becker muscular dystrophies
- 16 November 2022
- Published by Elsevier in Gait & Posture
- Vol. 99, 139-145
Factors associated with balance ability in Duchenne and Becker muscular dystrophies
- 1 June 2017
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 21, e156
Riboflavin responsive neuromusculary disorders; broad phenotypic spectrum and importance of genetic analyses
- 1 June 2017
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 21, e156
Riboflavin responsive neuromusculary disorders; broad phenotypic spectrum and importance of genetic analyses
- 1 June 2017
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 21, e228
Nerve conduction study findings in children with cystic fibrosis
- 1 June 2017
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 21, e228
Nerve conduction study findings in children with cystic fibrosis
- 1 June 2017
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 21, e36-e37
Alternative medications for epilepsy of infancy with migrating focal seizures; Potassium bromide and ketogenic diet
- 1 June 2017
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 21, e36-e37
Alternative medications for epilepsy of infancy with migrating focal seizures; Potassium bromide and ketogenic diet
- 1 June 2017
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 21, e117
Anti-MOG positive pediatric cases with diverse clinical spectrum in demyelinating disorders
- 1 June 2017
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 21, e117
Anti-MOG positive pediatric cases with diverse clinical spectrum in demyelinating disorders
- 11 June 2014
- Published by Springer Nature in Neurological Sciences
- Vol. 35 (11) , 1769-1775
Zonisamide attenuates hyperoxia-induced apoptosis in the developing rat brain
Oxygen therapy used in the treatment of perinatal hypoxia induces neurodegeneration in babies with immature antioxidant mechanisms. Zonisamide is a new antiepileptic drug used in childhood intractable seizures. Many studies demonstrated its neuroprotective effects. There is no study evaluating its effect on hyperoxic brain injury. The aim of this study was to investigate the neuroprotective effect of zonisamide on hyperoxia-induced neonatal brain injury. A total of 21 Wistar rat pups were used. The animals were divided into three groups: control group, hyperoxia group, and zonisamide-treated group. The zonisamide-treated group received an intraperitoneal injection of zonisamide. Zonisamide significantly preserved the number of neurons in CA1 and dentate gyrus parts of hippocampus, prefrontal, and parietal cortex. Zonisamide treatment also decreased the number of apoptotic neurons in all examined parts of hippocampus, prefrontal, and parietal cortex. We suggest that zonisamide treatment may be used as a neuroprotective agent in hyperoxic brain injury.
- 11 June 2014
- Published by Springer Nature in Neurological Sciences
- Vol. 35 (11) , 1769-1775
Zonisamide attenuates hyperoxia-induced apoptosis in the developing rat brain
Oxygen therapy used in the treatment of perinatal hypoxia induces neurodegeneration in babies with immature antioxidant mechanisms. Zonisamide is a new antiepileptic drug used in childhood intractable seizures. Many studies demonstrated its neuroprotective effects. There is no study evaluating its effect on hyperoxic brain injury. The aim of this study was to investigate the neuroprotective effect of zonisamide on hyperoxia-induced neonatal brain injury. A total of 21 Wistar rat pups were used. The animals were divided into three groups: control group, hyperoxia group, and zonisamide-treated group. The zonisamide-treated group received an intraperitoneal injection of zonisamide. Zonisamide significantly preserved the number of neurons in CA1 and dentate gyrus parts of hippocampus, prefrontal, and parietal cortex. Zonisamide treatment also decreased the number of apoptotic neurons in all examined parts of hippocampus, prefrontal, and parietal cortex. We suggest that zonisamide treatment may be used as a neuroprotective agent in hyperoxic brain injury.
- 12 February 2014
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 50 (7) , 553-556
The efficacy and safety of levetiracetam in paediatric patients treated with chemotherapeutic agents for haematologic disorders
- 12 February 2014
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 50 (7) , 553-556
The efficacy and safety of levetiracetam in paediatric patients treated with chemotherapeutic agents for haematologic disorders
- 7 November 2013
- Vol. 55 (2) , 235-6
A case of atypical Miller Fisher syndrome with negative anti-GQ1b immunoglobulin G and importance of H reflex.
- 7 November 2013
- Vol. 55 (2) , 235-6
A case of atypical Miller Fisher syndrome with negative anti-GQ1b immunoglobulin G and importance of H reflex.